Date | Title | Description | |
---|---|---|---|
25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download |
21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download |
21 Feb 2023 | On business and financial situation | The Company releases the press release related to the full year 2022 financial results. | Download |
21 Feb 2023 | On business and financial situation | The company releases the Integrated Report for the year 2022 | Download |
21 Feb 2023 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors | Download |
Pages
Date | Title | Description | |
---|---|---|---|
26 Jun 2023 | Other relevant information | The Company informs about the dividends payment | Download |
14 Jun 2023 | Announcement of general shareholders’ meeting | ROVI releases the information related to its General Shareholders Meeting. | Download |
31 May 2023 | Other relevant information | ROVI informs about the news items that have appeared in several media today regarding ROVI’s receipt of government grants | Download |
10 May 2023 | Announcement of General Shareholders’ Meeting | ROVI releases the information related to its General Shareholders Meeting | Download |
10 Apr 2023 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the first quarter of 2023 | Download |
Pages
Date | Title | Description | |
---|---|---|---|
12 Jun 2013 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
06 Jun 2013 | Otros sobre negocio y situación financiera | Download | |
24 Apr 2013 | Información sobre resultados (2) | Download | |
24 Apr 2013 | Información sobre resultados | Download | |
24 Apr 2013 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download |